Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3094 | 88-04-0 |
None
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,IKBKB,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 | 57 | |||
| kinase-selectivity-class | ACVR2B,AXL,BRAF,DDR1,GRK2,MAP2K6,MAPK7,PDK4,SIK2,TEK | 10 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 4721.34 | 99.34 | 1249 | 5987 | 143809 | 90477402 |
| Toxicity to various agents | 2369.92 | 99.34 | 871 | 6365 | 286975 | 90334236 |
| Drug abuse | 1623.71 | 99.34 | 485 | 6751 | 81862 | 90539349 |
| Respiratory arrest | 1285.70 | 99.34 | 333 | 6903 | 32978 | 90588233 |
| Poisoning | 1146.46 | 99.34 | 261 | 6975 | 14956 | 90606255 |
| Cardio-respiratory arrest | 1058.10 | 99.34 | 329 | 6907 | 62811 | 90558400 |
| Cardiac arrest | 1010.84 | 99.34 | 360 | 6876 | 104575 | 90516636 |
| Death | 852.96 | 99.34 | 497 | 6739 | 456054 | 90165157 |
| Intentional product misuse | 513.11 | 99.34 | 211 | 7025 | 89393 | 90531818 |
| Exposure via ingestion | 467.10 | 99.34 | 92 | 7144 | 2575 | 90618636 |
| Intentional overdose | 366.93 | 99.34 | 169 | 7067 | 93665 | 90527546 |
| Overdose | 337.71 | 99.34 | 189 | 7047 | 157520 | 90463691 |
| Alcohol poisoning | 133.94 | 99.34 | 31 | 7205 | 1881 | 90619330 |
| Alcohol use | 126.47 | 99.34 | 29 | 7207 | 1688 | 90619523 |
| Suicide attempt | 125.62 | 99.34 | 77 | 7159 | 75322 | 90545889 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 3433.72 | 80.03 | 1079 | 6849 | 95386 | 42518021 |
| Drug abuse | 2951.86 | 80.03 | 983 | 6945 | 103788 | 42509619 |
| Toxicity to various agents | 2364.34 | 80.03 | 1032 | 6896 | 228104 | 42385303 |
| Poisoning | 1108.30 | 80.03 | 298 | 7630 | 14401 | 42599006 |
| Respiratory arrest | 1025.35 | 80.03 | 325 | 7603 | 28099 | 42585308 |
| Cardio-respiratory arrest | 935.28 | 80.03 | 365 | 7563 | 58271 | 42555136 |
| Cardiac arrest | 687.75 | 80.03 | 355 | 7573 | 108965 | 42504442 |
| Intentional product misuse | 607.17 | 80.03 | 273 | 7655 | 61627 | 42551780 |
| Death | 596.16 | 80.03 | 568 | 7360 | 470617 | 42142790 |
| Exposure via ingestion | 596.12 | 80.03 | 125 | 7803 | 1997 | 42611410 |
| Intentional overdose | 248.96 | 80.03 | 141 | 7787 | 51315 | 42562092 |
| Overdose | 211.92 | 80.03 | 167 | 7761 | 105097 | 42508310 |
| Alcohol poisoning | 95.35 | 80.03 | 40 | 7888 | 7534 | 42605873 |
| Drug ineffective | 91.27 | 80.03 | 7 | 7921 | 630190 | 41983217 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Completed suicide | 8325.76 | 95.71 | 2443 | 12526 | 239938 | 110334392 |
| Drug abuse | 4586.12 | 95.71 | 1449 | 13520 | 175962 | 110398368 |
| Toxicity to various agents | 4516.51 | 95.71 | 1849 | 13120 | 478706 | 110095624 |
| Respiratory arrest | 2378.04 | 95.71 | 681 | 14288 | 57618 | 110516712 |
| Poisoning | 2235.24 | 95.71 | 561 | 14408 | 28544 | 110545786 |
| Cardio-respiratory arrest | 2009.95 | 95.71 | 705 | 14264 | 115131 | 110459199 |
| Cardiac arrest | 1747.25 | 95.71 | 735 | 14234 | 196018 | 110378312 |
| Death | 1620.57 | 95.71 | 1057 | 13912 | 697812 | 109876518 |
| Intentional product misuse | 1138.13 | 95.71 | 485 | 14484 | 132419 | 110441911 |
| Exposure via ingestion | 1035.97 | 95.71 | 216 | 14753 | 4684 | 110569646 |
| Intentional overdose | 588.52 | 95.71 | 308 | 14661 | 132193 | 110442137 |
| Overdose | 587.75 | 95.71 | 375 | 14594 | 233419 | 110340911 |
| Alcohol use | 358.17 | 95.71 | 88 | 14881 | 4034 | 110570296 |
| Drug ineffective | 166.86 | 95.71 | 10 | 14959 | 1520530 | 109053800 |
| Alcohol poisoning | 159.56 | 95.71 | 56 | 14913 | 8964 | 110565366 |
| Off label use | 142.60 | 95.71 | 18 | 14951 | 1500167 | 109074163 |
| Accidental death | 127.92 | 95.71 | 41 | 14928 | 4968 | 110569362 |
| Dyspnoea | 122.06 | 95.71 | 7 | 14962 | 1106865 | 109467465 |
| Fatigue | 121.95 | 95.71 | 12 | 14957 | 1215946 | 109358384 |
| Environmental exposure | 117.20 | 95.71 | 23 | 14946 | 361 | 110573969 |
| Suicide attempt | 112.87 | 95.71 | 101 | 14868 | 103293 | 110471037 |
| Poisoning deliberate | 110.26 | 95.71 | 59 | 14910 | 26272 | 110548058 |
| Headache | 105.84 | 95.71 | 3 | 14966 | 882374 | 109691956 |
| Pain | 102.35 | 95.71 | 7 | 14962 | 954948 | 109619382 |
| Blood ethanol increased | 99.89 | 95.71 | 22 | 14947 | 619 | 110573711 |
| Unresponsive to stimuli | 98.09 | 95.71 | 76 | 14893 | 63714 | 110510616 |
| Rash | 97.68 | 95.71 | 3 | 14966 | 820961 | 109753369 |
None
| Source | Code | Description |
|---|---|---|
| ATC | D08AE05 | DERMATOLOGICALS ANTISEPTICS AND DISINFECTANTS ANTISEPTICS AND DISINFECTANTS Phenol and derivatives |
| MeSH PA | D000871 | Anthelmintics |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000891 | Anti-Infective Agents, Local |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000980 | Antiplatyhelmintic Agents |
| MeSH PA | D004202 | Disinfectants |
| MeSH PA | D012556 | Schistosomicides |
| CHEBI has role | CHEBI:33904 | molluscicides |
| CHEBI has role | CHEBI:48218 | antiseptics |
| CHEBI has role | CHEBI:48219 | disinfectants |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Antiseptic preparation | indication | 261276004 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.85 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2B | GPCR | Ki | 5.93 | DRUG MATRIX | |||||
| Amine oxidase [flavin-containing] A | Enzyme | IC50 | 5.74 | DRUG MATRIX |
| ID | Source |
|---|---|
| 4019458 | VUID |
| N0000147580 | NUI |
| D03473 | KEGG_DRUG |
| 4018914 | VANDF |
| 4019458 | VANDF |
| C0055463 | UMLSCUI |
| CHEBI:34393 | CHEBI |
| CHEMBL398440 | ChEMBL_ID |
| DB11121 | DRUGBANK_ID |
| 2723 | PUBCHEM_CID |
| 492 | INN_ID |
| C007027 | MESH_SUPPLEMENTAL_RECORD_UI |
| 0F32U78V2Q | UNII |
| 20877 | RXNORM |
| 4423 | MMSL |
| 72857 | MMSL |
| 003140 | NDDF |
| 003202 | NDDF |
| 126151007 | SNOMEDCT_US |
| 398713003 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Antibacterial Hand | HUMAN OTC DRUG LABEL | 1 | 0404-4438 | SOAP | 6.10 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Antibacterial | HUMAN OTC DRUG LABEL | 1 | 0404-4441 | LIQUID | 6.05 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Antimicrobial Hand Wash | HUMAN OTC DRUG LABEL | 1 | 0404-5987 | SOAP | 6 mg | TOPICAL | OTC monograph not final | 11 sections |
| Antimicrobial Hand Wash | HUMAN OTC DRUG LABEL | 1 | 0404-5990 | SOAP | 6 mg | TOPICAL | OTC monograph not final | 11 sections |
| Blistex Foille Medicated First Aid | HUMAN OTC DRUG LABEL | 2 | 10157-9302 | OINTMENT | 0.10 g | TOPICAL | OTC monograph drug | 13 sections |
| PC511 ANTIMICROBIAL | HUMAN OTC DRUG LABEL | 1 | 10685-511 | SOAP | 3 g | TOPICAL | OTC monograph not final | 9 sections |
| PC529 ULTREX | HUMAN OTC DRUG LABEL | 1 | 10685-529 | SOAP | 2.50 g | TOPICAL | OTC monograph not final | 9 sections |
| PC537 E-2 BRUTE | HUMAN OTC DRUG LABEL | 1 | 10685-537 | SOAP | 25 g | TOPICAL | OTC monograph not final | 9 sections |
| PC557 PALPON | HUMAN OTC DRUG LABEL | 1 | 10685-557 | SOAP | 2.50 g | TOPICAL | OTC monograph not final | 9 sections |
| NAMICO ANTISEPTIC HAND CLEANER 557 | HUMAN OTC DRUG LABEL | 1 | 10685-978 | SOAP | 2.50 g | TOPICAL | OTC monograph not final | 9 sections |
| Derma CIDOL 2000 | HUMAN OTC DRUG LABEL | 1 | 10802-8081 | LIQUID | 0.50 g | TOPICAL | OTC monograph not final | 8 sections |
| Kindest Kare Hand Antimicrobial Handwash | HUMAN OTC DRUG LABEL | 1 | 11084-036 | SOAP | 1 g | TOPICAL | OTC monograph drug | 12 sections |
| PureBac Foam Wash | HUMAN OTC DRUG LABEL | 1 | 11084-131 | LIQUID | 0.50 mL | TOPICAL | OTC monograph not final | 9 sections |
| Acute-KareHealthcare Personnel Handwash | HUMAN OTC DRUG LABEL | 1 | 11084-800 | SOAP | 1 g | TOPICAL | OTC MONOGRAPH DRUG | 12 sections |
| FoamFresh Antibacterial Hand Wash | HUMAN OTC DRUG LABEL | 1 | 11429-1005 | LIQUID | 2.50 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Lemon Drop Gentle Antiseptic | HUMAN OTC DRUG LABEL | 1 | 11429-1006 | LIQUID | 3 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| FoamFresh Dye Free Antibacterial Hand Wash | HUMAN OTC DRUG LABEL | 1 | 11429-1010 | SOLUTION | 2.50 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Antiseptic Hand | HUMAN OTC DRUG LABEL | 1 | 16496-544 | SOAP | 3 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| BD E-Z SCRUB | HUMAN OTC DRUG LABEL | 1 | 17271-116 | SOLUTION | 30 mg | TOPICAL | OTC Monograph Drug | 14 sections |
| Renown Antibacterial Hand | HUMAN OTC DRUG LABEL | 1 | 18949-051 | LIQUID | 3000 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| LUCKYANTIBACTERIAL HAND | HUMAN OTC DRUG LABEL | 1 | 20276-151 | LIQUID | 0.30 g | TOPICAL | OTC monograph not final | 10 sections |
| SEPTISURGE | HUMAN OTC DRUG LABEL | 1 | 21532-5572 | SOAP | 2.50 g | TOPICAL | OTC monograph not final | 9 sections |
| GOJO RICH PINK Antibacterial Ltn Sp | HUMAN OTC DRUG LABEL | 1 | 21749-060 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Luxury Foam Antibacterial | HUMAN OTC DRUG LABEL | 1 | 21749-080 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| Premium Foam Antibacterial | HUMAN OTC DRUG LABEL | 1 | 21749-085 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| PROVON Foaming Antimicrobial Handwash with Moisturizers | HUMAN OTC DRUG LABEL | 1 | 21749-090 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| MICRELL Antibacterial Foam Handwash | HUMAN OTC DRUG LABEL | 1 | 21749-095 | LIQUID | 0.01 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| GOJO Ultra Mild Antimicrobial Ltn Sp with Chloroxylenol | HUMAN OTC DRUG LABEL | 1 | 21749-211 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| PURELL Healthy Sp Antibacterial Ltn Sp with PCMX | HUMAN OTC DRUG LABEL | 1 | 21749-423 | LIQUID | 0.30 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| GOJO PCMX E-2 Sanitizing Ltn Sp | HUMAN OTC DRUG LABEL | 1 | 21749-457 | LIQUID | 0.00 mg | TOPICAL | OTC Monograph Drug | 10 sections |